Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sangaletti, S. Articles by Colombo, M. P. Search for Related Content PubMed PubMed Citation Articles by Sangaletti, S. Articles by Colombo, M. P. Social Bookmarking                      What's this?

¹ Immunotherapy and Gene Therapy Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, 20133 Milan, Italy
² Department of Experimental Medicine and Pathology, Second Faculty of Medicine, University of Rome "La Sapienza," 00100 Rome, Italy

Address correspondence to Mario P. Colombo, Immunotherapy and Gene Therapy Unit, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy. Phone: 39-02-2390-2252; Fax: 39-02-2390-2630; email: mcolombo{at}istitutotumori.mi.it

Secreted protein, acidic and rich in cysteine (SPARC), also known as osteonectin or BM-40, is a Ca²⁺-binding matricellular glycoprotein involved in development, wound healing, and neoplasia. However, the role of SPARC in tumors is ill defined mostly because it is expressed by both tumor and stromal cells, especially inflammatory cells. We analyzed the respective roles of host- and tumor-derived SPARC in wild-type and congenic SPARC knockout (SPARC^-/-) mice on a BALB/c genetic background injected into the mammary fat pad with SPARC-producing mammary carcinoma cells derived from c-erB2 transgenic BALB/c mice. Reduced tumor growth but massive parenchyma infiltration, with large areas of necrosis and impaired vascularization were observed in SPARC^-/- mice. Immunohistochemical analysis showed a defect in collagen type IV deposition in the stroma of lobular tumors from SPARC^-/- mice. Chimeric mice expressing SPARC only in bone marrow–derived cells were able to organize peritumoral and perilobular stroma, whereas reciprocal chimeras transplanted with bone marrow from SPARC^-/- mice developed tumors with less defined lobular structures, lacking assembled collagen type IV and with a parenchyma heavily infiltrated by leukocytes. Together, the data indicate that SPARC produced by host leukocytes, rather than the tumor, determines the assembly and function of tumor-associated stroma through the organization of collagen type IV.

Key Words: osteonectin • extracellular matrix • leukocyte infiltration • tumor–host interactions

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Martinek, N., Shahab, J., Saathoff, M., Ringuette, M. (2008). Haemocyte-derived SPARC is required for collagen-IV-dependent stability of basal laminae in Drosophila embryos. J. Cell Sci. 121: 1671-1680 [Abstract] [Full Text]  
• Said, N., Socha, M. J., Olearczyk, J. J., Elmarakby, A. A., Imig, J. D., Motamed, K. (2007). Normalization of the Ovarian Cancer Microenvironment by SPARC. Mol Cancer Res 5: 1015-1030 [Abstract] [Full Text]  
• Sansom, O. J, Mansergh, F. C, Evans, M. J, Wilkins, J. A, Clarke, A. R (2007). Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice. Gut 56: 1410-1414 [Abstract] [Full Text]  
• Gregorieff, A., Clevers, H. (2007). Giving APCmin tumours a SPARC. Gut 56: 1341-1343 [Full Text]  
• Martinek, N., Shahab, J., Sodek, J., Ringuette, M. (2007). Is SPARC an Evolutionarily Conserved Collagen Chaperone?. J. Dent. Res. 86: 296-305 [Abstract] [Full Text]  
• Kelly, K. A., Allport, J. R., Yu, A. M., Sinh, S., Sage, E. H., Gerszten, R. E., Weissleder, R. (2007). SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J. Leukoc. Biol. 81: 748-756 [Abstract] [Full Text]  
• Chiodoni, C., Iezzi, M., Guiducci, C., Sangaletti, S., Alessandrini, I., Ratti, C., Tiboni, F., Musiani, P., Granger, D. N., Colombo, M. P. (2006). Triggering CD40 on endothelial cells contributes to tumor growth. J. Exp. Med. 203: 2441-2450 [Abstract] [Full Text]  
• Kzhyshkowska, J., Workman, G., Cardo-Vila, M., Arap, W., Pasqualini, R., Gratchev, A., Krusell, L., Goerdt, S., Sage, E. H. (2006). Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC. J. Immunol. 176: 5825-5832 [Abstract] [Full Text]  
• Mantovani, A. (2006). Linking Inflammation and Cancer: The Chemokine Connection in Mestastasis. aacredbook 2006: 7-10 [Full Text]  
• Yan, Q., Perdue, N., Blake, D., Sage, E. H. (2005). Absence of SPARC in Murine Lens Epithelium Leads to Increased Deposition of Laminin-1 in Lens Capsule. IOVS 46: 4652-4660 [Abstract] [Full Text]  
• Colombo, M. P., Mantovani, A. (2005). Targeting Myelomonocytic Cells to Revert Inflammation-Dependent Cancer Promotion. Cancer Res. 65: 9113-9116 [Abstract] [Full Text]  
• Gruber, H. E., Sage, E. H., Norton, H. J., Funk, S., Ingram, J., Hanley, E. N. Jr. (2005). Targeted Deletion of the SPARC Gene Accelerates Disc Degeneration in the Aging Mouse. J. Histochem. Cytochem. 53: 1131-1138 [Abstract] [Full Text]  
• Sangaletti, S., Gioiosa, L., Guiducci, C., Rotta, G., Rescigno, M., Stoppacciaro, A., Chiodoni, C., Colombo, M. P. (2005). Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J. Cell Sci. 118: 3685-3694 [Abstract] [Full Text]  
• Alvarez, M. J., Prada, F., Salvatierra, E., Bravo, A. I., Lutzky, V. P., Carbone, C., Pitossi, F. J., Chuluyan, H. E., Podhajcer, O. L. (2005). Secreted Protein Acidic and Rich in Cysteine Produced by Human Melanoma Cells Modulates Polymorphonuclear Leukocyte Recruitment and Antitumor Cytotoxic Capacity. Cancer Res. 65: 5123-5132 [Abstract] [Full Text]  
• Mikaelsson, E., Danesh-Manesh, A. H., Luppert, A., Jeddi-Tehrani, M., Rezvany, M.-R., Sharifian, R. A., Safaie, R., Roohi, A., Osterborg, A., Shokri, F., Mellstedt, H., Rabbani, H. (2005). Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 105: 4828-4835 [Abstract] [Full Text]  
• De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., Musiani, P., Zanovello, P., Bronte, V. (2005). Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl. Acad. Sci. USA 102: 4185-4190 [Abstract] [Full Text]  
• Puolakkainen, P. A., Brekken, R. A., Muneer, S., Sage, E. H. (2004). Enhanced Growth of Pancreatic Tumors in SPARC-Null Mice Is Associated With Decreased Deposition of Extracellular Matrix and Reduced Tumor Cell Apoptosis. Mol Cancer Res 2: 215-224 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS